AnaptysBio Inc buy Guggenheim
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€34.37
Performance (%)
115.28%
Price
04.11.25
€30.40
Summary
This prediction is currently active. The BUY prediction by Guggenheim for AnaptysBio Inc has seen massive gains of 115.28%. This prediction currently runs until 12.12.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 0.649% | 0.649% |
| iShares Core DAX® | -1.602% | -2.113% |
| iShares Nasdaq 100 | -0.781% | 4.974% |
| iShares Nikkei 225® | 1.289% | 9.118% |
| iShares S&P 500 | -0.258% | 3.131% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Guggenheim from $90.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat